Učitavanje...
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
BACKGROUND: One-third of estrogen (ER+) and/or progesterone receptor-positive (PGR+) breast tumors treated with Tamoxifen (TAM) do not respond to initial treatment, and the remaining 70% are at risk to relapse in the future. Estrogen-related receptor gamma (ESRRG, ERRγ) is an orphan nuclear receptor...
Spremljeno u:
| Izdano u: | J Exp Clin Cancer Res |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436109/ https://ncbi.nlm.nih.gov/pubmed/25971350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0150-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|